
Endocrine-Related Cancer
@EndoCancer
Followers
3K
Following
1K
Media
1K
Statuses
2K
Publishing translational & clinical investigations of human health & disease focusing on #endocrine neoplasias & hormone-dependent #cancers. Owned by @soc_endo.
Joined August 2014
🌟We are delighted to announce that Prof. Alfred Lam, Professor of Pathology at @Griffith_Health, has joined Endocrine-Related Cancer's editorial board as an Associate Editor. Explore his recent research article on the rising incidence of thyroid cancer:
0
0
0
Sponsored by @CureNETs, this $100,000 grant is designed to help an early-career, basic or clinical scientist conduct novel and innovative #NETs research. Learn more: . #neuroendocrinecancer #earlycareerresearcher
0
0
1
🧪New research by Jinheng Xiao et al. explores the distinct metabolic profiles of parathyroid carcinoma and parathyroid adenoma, identifying promising biomarkers for preoperative diagnosis of parathyroid carcinoma. Read the full article #OpenAccess:
0
0
1
📢Are you attending #ENDO2025? Come and visit the Bioscientifica booth, 803, to find out more about publishing in Endocrine-Related Cancer!🙌✨
0
1
4
🧬New research by Mina Sattari (@Tays_sairaala) et al. identifies 85 metastatic castration-resistant prostate cancer-associated genes, spotlighting TMEM18 as a promising prognostic biomarker in early prostate cancer. Explore the full article #OpenAccess:
0
0
0
Delighted to have achieved an increased Journal Impact Factor of 4.6 in the latest #JCR2025 report @ClarivateAG!. Thanks to our authors, reviewers and editors for your valued contributions & collaboration. Explore the top-cited articles that contributed👉
1
0
0
Discover the latest review in the #RET Special Collection: 'Biology of RET receptor and its ligands: focus on the nervous system'. By Arun Kumar Mahato and Mart Saarma @helsinkiuni. 👉Subscribers can access the full article here:
0
0
0
RT @Marta_Araujo_C: 💢💢The result of a collaborative project among @sociedadSEEN.@GrupoGetne.@aecirujanos @_SEOM.@SEMNIMoficial #SEOR @SEAP_….
0
19
0
RT @DrMHofman: Peptide receptor radionuclide therapy in malignant insulinoma. Wonderful work from @DrDavePattison . "PRRT provides durabl….
0
4
0
✨Contribute to our Special Collection, The Biology of Aging and Endocrine-Related Cancers, and showcase your research on how aging biology affects endocrine-related cancer risk, treatment responses, and patient outcomes. 📨Submit your proposal today: erc@bioscientifica.com
0
0
1
This latest review by Arun Kumar Mahato and Mart Saarma @helsinkiuni looks into the critical role of RET receptor signaling in the nervous system, development, and disease. 🔗Subscribers of Endocrine-Related Cancer can access the full article here:
0
0
1
Immune evasion in neuroendocrine neoplasms: what part do CXC chemokines play?.This comprehensive review by Karolina Merecz @umedlodz et al. unpacks the emerging evidence. 🔗Subscribers of Endocrine-Related Cancer can read the full article here:
0
0
0
🌟Emerging Leaders 2026 🌟 .We’re celebrating early-career excellence in endocrine-related cancer research!.Nominate a researcher for our Emerging Leaders 2026 special collection. Contact erc@bioscientifica.com with their CV & proposed article type and topic for consideration.
0
0
0
Check out this new research by Nelson Rangel @UniJaveriana et al. exploring surrogate molecular classification of LAR #BreastCancer in routine workflows, highlighting this distinct TNBC subtype and its therapeutic potential. 🔗Read the full article here:
0
0
0